Long-term visual outcomes for treatment of submacular haemorrhage secondary to polypoidal choroidal vasculopathy.
Hyun Goo KangHyunseung KangSuk Ho ByeonSung Soo KimHyoung Jun KohSung Chul LeeMin KimPublished in: Clinical & experimental ophthalmology (2018)
IVB monotherapy appears to be as effective as combination therapies for treating SMH secondary to PCV with regards to BCVA at 24 months, and may be a cost-effective strategy for long-term management.